Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

Rhea-AI Summary

Haemonetics (NYSE: HAE) posted its third quarter fiscal 2026 results for the period ended December 27, 2025, on its Investor Relations website.

The company will host a conference call and live webcast at 8:00 a.m. ET on February 5, 2026, with a replay available from 11:00 a.m. ET on February 5, 2026 for one year. Earnings release and a supplemental presentation are posted and will be referenced on the call.

News Market Reaction – HAE

-1.41%

39 alerts

-1.41% Session close to close

-5.2% Trough in 5 hr 44 min

$2.90B Market Cap

1.5x Rel. Volume

In the Feb 5 session, HAE declined 1.41%, reflecting a mild negative market reaction. Argus tracked a trough of -5.2% from its starting point during tracking. Our momentum scanner triggered 39 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement directs investors to Haemonetics’ full third quarter FY2026 results and supplement...

Analysis

This announcement directs investors to Haemonetics’ full third quarter FY2026 results and supplemental materials, plus an 8:00 a.m. ET call and one-year replay. Historically, similar earnings postings have produced sizable moves both up and down, such as +32.31% and -26.58%. Key items to watch in the materials include revenue trends, profitability, cash flow, and any updated guidance or portfolio commentary.

Key Figures

Quarter end date: December 27, 2025 Earnings call time: 8:00 a.m. ET Replay start time: 11:00 a.m. ET +1 more

4 metrics

Quarter end date December 27, 2025 Third quarter fiscal 2026 period end

Earnings call time 8:00 a.m. ET Conference call start on February 5, 2026

Replay start time 11:00 a.m. ET Replay availability on February 5, 2026

Replay duration 1 year Replay accessible via webcast link

Previous Earnings Reports

5 past events · Latest: Nov 06 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 06	Q2 FY26 earnings	Neutral	+32.3%	Second quarter FY26 results posted with webcast and replay details.
Aug 07	Q1 FY26 earnings	Neutral	-26.6%	First quarter FY26 financial results posted and discussed via webcast.
May 08	FY25 results	Neutral	+5.8%	Fourth quarter and full-year FY25 results with guidance materials released.
Feb 06	Q3 FY25 earnings	Neutral	-11.6%	Third quarter FY25 results made available with investor call and replay.
Nov 07	Q2 FY25 earnings	Neutral	+10.7%	Second quarter FY25 results posted with conference call and webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings postings have historically driven large bidirectional moves, with reactions ranging from about -26.58% to +32.31%, indicating that quarterly updates have been important trading catalysts.

Recent Company History

This announcement continues Haemonetics’ practice of posting full quarterly results and materials to its Investor Relations site and pairing them with an 8:00 a.m. ET call. Recent history includes the Vivasure Medical acquisition valued up to €185M, a J.P. Morgan Healthcare Conference presentation on Jan 13, 2026, and prior earnings releases such as Q2 FY26 on Nov 6, 2025, which saw a 32.31% move.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Financial release and supplemental presentation accessible online

BOSTON, Feb. 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2026, which ended December 27, 2025, are available on the Company's Investor Relations website at www.haemonetics.com.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 5, 2026.

Conference Call and Webcast Information:

• Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
• Live webcast: Access here or through the Investor Relations section of the Haemonetics website.

A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on February 5, 2026 and will remain accessible for one year via the webcast link above.

Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:

• Third Quarter Fiscal 2026 Earnings Release
• Third Quarter Fiscal 2026 Supplemental Earnings Presentation

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com
david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-third-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302679292.html

SOURCE Haemonetics Corporation

FAQ

When did Haemonetics (HAE) report its third quarter fiscal 2026 results?

Haemonetics reported Q3 fiscal 2026 results for the period ended December 27, 2025. According to the company, the earnings release and supplemental presentation are posted on its Investor Relations website for review.

What time is the Haemonetics (HAE) Q3 2026 earnings conference call and webcast?

The conference call and webcast will start at 8:00 a.m. ET on February 5, 2026. According to the company, registration provides dial-in details and a personalized PIN and joining 10 minutes early is recommended.

How can investors access the Haemonetics (HAE) earnings materials and webcast replay?

Earnings materials and the live webcast are available on the Haemonetics Investor Relations website. According to the company, a replay begins at 11:00 a.m. ET on February 5, 2026 and will remain available for one year.

What materials did Haemonetics (HAE) post for Q3 fiscal 2026?

Haemonetics posted a Third Quarter Fiscal 2026 Earnings Release and a Supplemental Earnings Presentation on its Investor Relations site. According to the company, these documents will be referenced during the February 5 conference call and webcast.

Do participants need to register to join the Haemonetics (HAE) Q3 earnings call?

Registration is available and provides dial-in details and a personalized PIN, though it is not strictly required. According to the company, registration is recommended and will streamline access to the live conference call and webcast.